GE Healthcare partners with Amazon to deliver AI & cloud-based imaging solutions
Key Insights and Signals – Hospital & Healthcare
Centre setup and Expansion Bright Health is planning to expand into 42 new markets in 2022 Health insurer Bright HealthCare is expanding into 42 new markets for 2022, including Texas, Georgia, Utah, and Virginia. The expansion includes entry into several new states and growth within the states it already serves, bringing its total footprint to 17 states and 131 markets across the country. Read More>> Mayo Clinic to build USD 200 Mn proton beam expansion The expansion will add two new treatment rooms to the four Mayo now uses to treat patients dealing with prostate cancer, breast cancer, neck and throat cancers as well as pediatric cancers. Read More>>Deal and Deal Renewal VitalTech announces agreement with Vizient for its virtual care solutions The company’s comprehensive virtual care solution also encompasses onboarding, orientation, and monitoring services to assist with logistics, training, and compliance. VitalTech’s contract with Vizient went into effect on August 1, 2021. Read More>> Anthem Blue Cross, Dignity Health come to an agreement after eight months Anthem Blue Cross and Dignity Health announced a new deal that will return Dignity providers to Anthem health plans through April 2025. The contract will cover all care provided at Dignity Health since July 15; patients who made arrangements to seek their care through other providers get the option to return. Read More>>Partnerships Sensyne Health and Sentara Healthcare join hands for ethical data sharing and new clinical algorithms The partnership combines both life sciences research and healthcare algorithm development to deliver value back to Sentara and its patients. The agreement will enable the ethical application of clinical AI research by Sensyne through analyzing Sentara’s patient dataset to improve patient care and accelerate medical research. Read More>> TytoCare, Prisma Health partner to expand telehealth services Telehealth specialist TytoCare announced a partnership with Prisma Health that will enable its patients to perform telehealth-guided medical exams through Prisma providers. Prisma will also tap into the company’s telehealth services for use in schools, behavioral health, walk-in clinics , and senior care. Read More>>Executive Movement Johnson & Johnson names Joaquin Duato as its next CEO Duato has worked for Johnson & Johnson for more than 30 years and currently serves as the Vice-Chairman of Johnson & Johnson’s executive committee. Joaquin Duato will transition to the role of CEO on January 3, 2022, replacing Alex Gorsky. Read More>> Cerner appoints David Feinberg as President and CEO Feinberg will take over as president and CEO of Cerner, effective October 1, and join the company’s board of directors. He succeeds Brent Shafer as CEO, who will serve as senior advisor of the company for one year, and takes over the president role from Donald Trigg, who will leave the company. Read More>>Mergers and Acquisitions HealthCare at HOME (HCAH) acquires Suvitas Holistic Healthcare HCAH has acquired transition care firm SuVitas Holistic Healthcare in a cash and stock deal. The company did not provide any financial details of the agreement. Following the acquisition, SuVitas becomes a 100 percent subsidiary of the company. Read More>> Sharecare acquires CareLinx in a USD 65 Mn deal Through its network of over 450,000 tech-enabled caregivers, CareLinx delivers intermittent on-demand personal care services at home while leveraging mobile technology to facilitate rich data capture, population health analytics, and the enabling of real-time care coordination with remote clinical teams. Read More>>
Key Insights and Signals in Pharmaceuticals
Centre Setup and Expansion Cytiva and Pall to spend USD 1.5 Bn on manufacturing capacity expansion Cytiva and Pall Corporation, both subsidiaries of Danaher Corporation, have announced they are to invest USD 1.5 Bn to expand manufacturing capacity across 13 sites globally. The investment will include the doubling of capacity in multiple site locations and two new sites: one in the UK and one in the US. Read More>> Catalent announces USD 100 Mn expansion of Italian facility The expansion will enable it to add biologics drug substance manufacturing capabilities and support the growing European market for biologics. The first phase of the expansion will see the installation of two bioreactors within new, purpose-built manufacturing suites and associated investments. Read More>>Deal and Deal Renewal Wockhardt signs a pact with RDIF to manufacture 620 Mn doses of Sputnik Vaccines Mumbai-headquartered drug maker Wockhardt has entered into an agreement with the Russian Direct Investment Fund (RDIF) arm Enso Healthcare to make 620 Mn doses of the Sputnik V and Sputnik Light vaccines over the next two years. Read More>> Japan, Pfizer sign a deal for 120 Mn “booster” third vaccines The Japanese government and Pfizer have agreed to a contract supplying an additional 120 Mn doses of Pfizer’s coronavirus vaccines in 2022, as part of efforts to administer “booster” third doses. The Japanese government has also begun investigations into giving medical professionals and elderly people third doses upon completion of their second shots. Read More>>Partnerships Roche and KeChow collaborate to promote Zelboraf in China The key objective of this cooperation agreement is to improve patients’ access to Zelboraf® in China. Zelboraf® is a small oral molecule, selective BRAF inhibitor indicated to treat patients with BRAF V600 mutation-positive advanced or inoperable melanoma. Read More>> Glenmark partners with SaNOtize to bring nasal spray for Covid to Asia The exclusive, long-term alliance allows Glenmark to manufacture, market, and distribute SaNOtize’s Nitric Oxide Nasal Spray (NONS) for Covid-19 in India and other Asian markets. Glenmark has sought regulatory clearance on the product and will undertake advanced clinical trials in India. Read More>>Executive Movement Cipla gets new CEO to replace Nevin Bradford Cipla is now set to receive a new managing director as Ajay Kumar Pal plans to take over the firm next month. Kumar will succeed Nevin Bradford, who has been CEO since 2013 and doubling as the executive director and head of Cipla’s Rest of Africa Business. Read More>> Eli Lilly splits and delegates Bio-Medicines unit to increase focus Eli Lilly & Co. unveiled plans to split its Lilly Bio-Medicines business into two units, Lilly Neuroscience and Lilly Immunology. Anne White, who currently serves as president of its Lilly Oncology unit, would become president of Lilly Neuroscience, responsible for the company’s launched products and Phase 3 portfolio in pain and neurodegeneration. Read More>>Mergers and Acquisition Aurobindo Pharma reports a USD 60 Mn deal to acquire 51% in Cronus Pharma canceled On August 12, the company had entered into a definitive agreement to subscribe to fresh equity shares in Cronus, a generic veterinary pharmaceutical products firm. However, due to reasons undisclosed, the board of directors have approved the termination of the aforesaid agreement, and the parties have mutually agreed and terminated the said agreement. Read More>> Bayer to acquire novel drug discovery company for USD 2 Bn Bayer is acquiring biopharma company Vividion Therapeutics, which uses novel discovery technologies to unlock high value, traditionally “undruggable” targets with precision therapeutics. Vividion’s proprietary platform can produce various small molecule therapies, yielding highly potent and selective compounds that can address areas of high unmet medical need. Read More>>
Key Insights and Signals in MedTech
Centre Setup and Expansion Abbott to invest USD 44.3 Mn in Clonmel R&D center The investment, which is being supported by the Government through IDA Ireland, will research several cardiovascular projects, including stents and endovascular balloons. The investment comes as Abbott marks its 75th year operating in Ireland. Read More>> Thermo Fisher Scientific opens cGMP Plasmid DNA manufacturing facility in California The 67,000-square-foot facility on the Carlsbad campus will enable the company to meet the rapidly growing demand for plasmid DNA-based therapies and vital mRNA-based vaccines. The expansion also benefits California’s growing life sciences ecosystem, and Thermo Fisher will add more than 150 new roles as manufacturing scales. Read More>>Deal and Deal Renewal GE Healthcare deploys VMware SD-WAN to deliver cloud-based services GE Healthcare recently launched OnWatch Network Edge to assist customers that use GE Healthcare’s cloud-hosted services. GE Healthcare leverages VMware SD-WAN with OnWatch Network Edge to deliver these services to customers without compromising the quality of service or security of patient data. Read More>> Cardinal Health extends pharmaceutical distribution agreements with CVS Health Cardinal Health will distribute pharmaceuticals to CVS Health’s retail pharmacies and distribution centers through June 30, 2027, under the extended agreement. Read More>>Partnerships GE Healthcare, Baxter among MedTech giants inking deals with Amazon Web Services GE Healthcare will work with AWS to deliver AI and cloud-based imaging solutions, integrated data, and clinical and operational insights to hospitals and healthcare providers. The news comes just weeks after Amazon unveiled its AWS for Health suite. Read More>>Executive Movement Stryker President Scannell to retire Stryker announced that after a thirty-one year career at Stryker, Timothy J. Scannell, President, and COO had notified the company of his intent to retire on March 31, 2023. Scannell will serve as Advisor to the CEO and provide counsel on a range of strategic issues and ensure a smooth transition of his duties. Read More>> GE Healthcare Korea names Kim Eun-mi as new CEO Kim has taken various positions at GE for more than two decades. She started in 2000 as the operation analyst of GE Healthcare and completed GE’s Financial Management Program. She then joined Corporate Audit Staff and developed leadership ability in Korea, US, and Taiwan. Read More>>Mergers and Acquisition Bioventus to acquire Misonix for USD 518 Mn The transaction is projected to close in the fourth quarter of 2021 and is subject to regulatory approvals. Misonix stockholders will receive stock or cash value estimates of around USD 518 million in total, based on weekly volume-weighted average stock prices. Read More>> Philip Morris wins the takeover battle for inhaler maker Vectura Vectura’s board of directors’ plan to unanimously recommend the 165p-a-share offer made by Philip Morris, which values the group at more than USD 1.3 bn. The recommendation was made despite more than 20 leading public health bodies, experts, and doctors have called for it to reject the deal. Read More>>
Latest Industry Insights from Draup Braindesk
Medtech companies are primarily focusing on digitization to sustain themselves in the market.
Roche is keen on developing diagnostic solutions for the early detection of cancers, hematologic disorders, and cardiovascular diseases.
It has partnered with Sysmex to deliver hematology testing solutions by utilizing IT systems to improve clinical decision-making.
Roche innovates digital imaging and image processing to help the diagnosis of cancer.
Digitization of medical tests and drug development are the key partnership areas for service providers.
Roche is currently working with 80+ outsourcing partners involved in Consulting & System Integration, Application Development & Maintenance, Infrastructure Management Services, Reporting & Analytics, Digital Services, and Product Engineering Services.
Demant focuses on the development of solutions & services for the hearing care and communication business.
Launched a Deep Neural Network for optimal hearing performance.
Demant launched VisualEyes for objective torsional eye movement analysis, 3D head modeling, and Saccadometry.
Demant is working with ~3 service providers, majorly around Reporting & Analytics related engagements.
Service Providers with expertise in providing Digital Health and Game Publishing will be the perfect outsourcing partners for Demant.
Latest Reports Published in Draup
Boston Scientific Account Intelligence Report: Boston Scientific aims to introduce advanced technology devices to improve the treatment procedure, help the patients find local physicians easily, and raise awareness about drug-free pain management. Boston Scientific is also positioning its future goals to enhance its capabilities across hardware offerings. Read More>>
CommonSpirit Health Account Intelligence Report: CommonSpirit health focuses on embracing telehealth services and solutions, enhancing its product offering to promote efficiency and deliver a decent consumer experience. CommonSpirit Health’s digital initiatives aim to provide virtual health solutions to improve their healthcare experience. Read More>>
Key Funding Alert
Catholic Health and Eastern Niagara Health System receive USD 18 Mn for a new hospital
This funding will support the continued access to vital public health services and the redesign of the healthcare delivery system into a sustainable model for the long term while assisting in providing financial stability during this transformation. Read More>>
Company – Fluresh Total Funding– USD 2.82 Mn Vertical – Medical Devices About: Fluresh, a premium vertically integrated medical cannabis company, cultivates and processes premium quality cannabis for dynamic needs. It aims to deliver the highest-quality medical cannabis products. It is headquartered in Grand Rapids, Michigan. Read More>>
Here’s what’s new on our Sales Intelligence Platform Filter Tech Stack & Use Cases with Keyword Search
Digital Tech Stack and Use Cases filter in Universe supports keyword search
View the Certifications in Demand in the Hiring section
View the Job Type information for the job postings in the Hiring section